explore -WSS

explore

author：knowledge 2025-10-02 21:07:10 - browse：6322

An illustrated portrait of Eli Lilly's David Ricks and Skovronsky – biotech and pharma coverage from STAT — Eli Lilly CEO David Ricks (left) and Chief Scientific Officer Daniel S. Skovronsky Molly Ferguson for STAT

The partnership that would shape Eli Lilly into one of the biggest success stories in the pharmaceutical industry began with conversations around a relatively minor acquisition.

At the time, David Ricks was running Lilly’s U.S. business and was part of the team charged with evaluating Avid Radiopharmaceuticals, which Lilly would go on to purchase in 2010 for a paltry $300 million — couch change for a multibillion-dollar firm. But what struck Ricks was not the company’s technology, for imaging Alzheimer’s plaques, but Avid’s CEO, Daniel S. Skovronsky.

“Dan’s different,” Ricks told STAT. “I had this sense immediately. Some people get in biotech for the cha-ching.” Skovronsky turned out to be a secret weapon. Within six months, Ricks had been promoted to run Lilly’s biomedicine unit and Skovronsky was working for him.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Free Covid tests will again be offered to all U.S. households

WSS

TikTok, Instagram influencers need more rules for drug ads

Transgender sports debate: Physicians say bans are health issue

FDA endorses new sterilization method for medical devices

Dog Aging Project founders on what lies ahead after losing funding

Maisha Meds is a PBM, but don't call it that

Prior authorization reform is both possible and imperative

leisure time

explore

leisure time

Trump demands the U.S. pay no more for drugs than other countries … again

Mass General, Mayo Clinic look to monetize custom

Novavax promises a turnaround & Lilly roils the obesity market

Mass General, Mayo Clinic look to monetize custom

Jerome Adams on the need for new antivirals for Covid

Printout prescription drug information shouldn’t go digital

Apple is now the first public company to be valued at $3 trillion

White House Covid adviser calls on docs to combat misinformation

Medical leaders decry Supreme Court decision on affirmative action

PBMs drew scrutiny in House hearing — and so did pharma

hotspot

Midwives could help bridge maternal health disparities in the U.S.

Midwives could help bridge maternal health disparities in the U.S.

To bolster infectious disease surveillance, genomics powerhouses team up

Senate bill would ban some hospital facility fees

FDA endorses new sterilization method for medical devices

Fed up with FDA, ALS advocates consider a take

knowledge

leisure time

entertainment

explore